Laura Shawver, a director at ARS Pharmaceuticals Inc. (NASDAQ:SPRY), has sold 50,000 shares of common stock, according to a recent filing with the Securities and Exchange Commission. The shares were ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...